
    
      The IN.PACT SFA Trial enrolled in 2 phases: IN.PACT SFA I and IN.PACT SFA II. The 150-patient
      IN.PACT SFA I phase is intended to support the second phase IN.PACT SFA II IDE trial with
      congruent design and protocol. Aggregate data from the two phases is intended to provide
      statistical power for the 12-month primary safety and effectiveness endpoints.
    
  